American Journal of BioMedicine Volume 2, Issue 11,
Abdulhamza Rajooj Hmood; Rawaa Hatif Abd ; Basma Edan Kadhum ; Saeed H. Lafta; khadeejh Rajooj Hmood
Beta-thalassemia intermedia exhibits feature of ineffective erythropoiesis and hemolytic anemia. Diagnosis can be made via hemoglobin electrophoresis. G6PD deficiency is an X-linked recessive disorder commonly affecting males while females are carrier. Diagnosis is made by measuring G6PD level. A 19-year old pregnant lady, known case of β-thalassemia intermedia, had been presented with episode of acute hemolytic anemia. Investigations were highly suggestive of G6PD deficient anemia. This was confirmed with low G6PD level. Back to her immediate history, consumption of broad bean was ascertained. After appropriate therapy, the patient felt better and her medical derangement was normalized. She delivered normally and kept on life-long folic acid therapy. The importance of recording such a case report is to expect unusual combination of hemolytic anemia despite the uncommon finding of X-linked recessive disorder in women. This was the first case recorded in Karbala province
Keywords: Beta-thalassemia; Erythropoiesis; G6PD; Hemolytic anemia
1. Flint J, Harding RM, Boyce AJ, Clegg JB. The population genetics of the hemoglobinopathies. Bailliere's Clinical Hematology 1998; 11:1-50.
2. Higgs DR, Thein SL, Woods WG. The molecular pathology of the thalassemias. In: Weatherall DJ, Clegg B, eds. The thalassaemia syndromes. 4th ed. Oxford, England: Blackwell Science 2001:133-91.
3. Pootrakul P, Sirankapracha P, Hemsorach S, et al. A correlation of erythrokinetics, ineffective erythropoiesis, and erythroid precursor apoptosis in Thai patients with thalassemia. Blood 2000; 96:2606-12.
4. Glader BE. Hemolytic anemia in children. Clin North Am 1999;19(1):89–111.
5. Vrettou C, Traeger-Synodinos J, Tzetis M, Malamis G, Kanavakis E. Rapid screening of multiple betaglobin gene mutations by real-time PCR on the Light Cycler: application to carrier screening and prenatal diagnosis of thalassemia syndromes. Clin Chem 2003; 49:769-776.
6. Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis 2009; 42(3):267-78.
7. Prchal JT, Gregg XT. Red Cell Enzymes. Hematology/ASH Education Book. Accessed 2014.
8. Frank JE. Diagnosis and management of G6PD deficiency. Am Fam Physician 2005;72(7):1277-82.
9. Manganelli G, Masullo U, Passarelli S, Filosa S. Glucose-6-phosphate dehydrogenase deficiency: disadvantages and possible benefits. Cardiovasc Hematol Disord Drug Targets 2013;13(1):73-82.
10. Kaplan M, Hammerman C. Glucose-6-phosphate dehydrogenase deficiency: a hidden risk for kernicterus.Semin Perinatol 2004;28(5):356-64.
11. McDade J, Abramova T, Mortier N, Howard T, Ware RE. A novel G6PD mutation leading to chronic hemolytic anemia. Pediatr Blood Cancer 2008;51(6):816-9.
12. Minucci A, Giardina B, Zuppi C, Capoluongo E. Glucose-6-phosphate dehydrogenase laboratory assay: How, when, and why? IUBMB Life 2009;61(1):27-34.